Companies › BFRI

BIOFRONTERA INC (BFRI)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001858685 · EDGAR filings · Updated 2026-07-22

BIOFRONTERA INC (BFRI) has reported institutional ownership of 20.5%, with 12 institutional managers holding positions valued at $1.94M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (2)

• 2026-07-22 — Employee-plan registration (S-8) filed
• 2026-07-22 — 10-K/A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-06-17 — Current report (8-K) filed
• 2026-05-14 — Quarterly report (10-Q) filed
• 2026-05-14 — Current report (8-K) filed
• 2026-04-30 — Proxy statement (DEF 14A) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, BIOFRONTERA INC has 12 institutional holders and institutional ownership of 20.5%.

Insider activity

Insiders reported 4 transactions (0 buys, 0 sells) across 8 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

Reviva Pharmaceuticals Holdings Inc (RVPH) · RADIOPHARM THERANOSTICS LTD (RADX) · PURETECH HEALTH PLC (PRTCY) · CRYO-CELL INTL INC (CCEL) · Dare Bioscience Inc (DARE) · Fresenius SE & Co KGaA (FSNUF)